Biomedical company conceived in London and founded in Italy

Biomedical company conceived in London and founded in Italy

IBD is an innovative SME, a manufacturer of biomedical devices conceived in London and founded in Italy in 2014.

Led by a team with more than 10 years of experience in medical device design, IBD has so far raised over € 1 million in business angel funding and grants.

It is now facing a new round of funding and is constantly looking for investors who believe in the values ​​and goals that drive IBD.

Our
Vision

IBD considers the Reverse Innovation of medical devices the key to making quality health care accessible to the whole world .

Our
Mission

Our mission is tackling health problems through the application of the principles of reverse innovation.

We observe the technological limitations and clinical needs existing in the global healthcare environment to create the best solution in terms of safety and efficacy , optimization of costs, and usability .

Our story

2014

Ghidini e Visotti

Development Activities

The MyDial technological concept has been formulated.

Foundation

In May 2014 Corrado Ghidini and Andrea Visotti founded the Start up IBD Srl and opened an R&D laboratory in Bologna (Italy).


2015 Area sviluppo IBD Biomed

Development Activities

The first prototype of MyDial was developed using a PC-controlled data acquisition platform.

2015


2016

Development Activities

The second prototype of MyDial, based on a first version of PC-independent embedded electronics, was developed and tested in the laboratory.


Development Activities

IBD prototyped the Manifold, improved the ultrafiltration control and started activities to obtain the CE certification of Dial-IT

2017 Gruppo Lavoro IBD Biomed

2017


2018

POR FESR call for innovative Startups

IBD obtained non-repayable loan of 100k€ from the Emilia-Romagna Region.

8d981281 90c3 488e 9690 d780dc8ec0d9

Third Prototype Tested and Validated

The third protype of MyDial has been tested and validated in vitro.


My Dial 2019

Industrialization and Certification process

Industrialization and Certification process Industrialization of the whole MyDial system and CE certification process begins, for hospital use.

Seals of Excellence Horizon 2020

Seals of Excellence Horizon 2020 Two more seals assigned by European Commission: 867214 – 888419

2019


2020

With the outbreak of the Covid-19 pandemic, Biorespira was born

To respond to the pandemic, engineers create the first prototype of the Biorespira lung ventilator in just 5 weeks.

Partnership with SECO Group for the industrialization of Biorespira

Partnership with SECO GROUP, a leading company in the hi-tech sector, specialized in IT miniaturization, supported by FII Tech Growth managed by the Italian Investment Fund SGR, for the industrialization of Biorespira.

Crowdfunding campaign #LETTHEMBREATHE

IBD has launched a successful crowdfunding campaign, called #LetThemBreathe, to support Biorespira’s development activities.

Development of BioRespira

During the COVID-19 pandemic, in an effort to help alleviate the emergency and shocked by the scarce presence of ventilator manufacturers in Italy, the team decided to develop a sub-intensive care ventilator with high flow and mixing of oxygen.

CE Biorespira certification

Biorespira has been tested and validated and CE certified by KIWA Cermet Italia.


Biorespira patent and registration in 20 countries

Italy Ireland, Austria, Germany, Luxembourg, Poland, Slovenia, France, Spain, Cyprus, Greece, Latvia, Portugal, Belgium, Netherlands, Croatia, Lithuania, Slovakia, Haiti, Cameroon.

Biorespira records illustrious names among its sales

Among the approximately 600 devices sold there is no shortage of important hospitals such as: Osp. Maggiore (Bo), Sant’Orsola Malpighi Polyclinic (Bo), Hospital. Sant’Eugenio (Rm).

First participation in Medica 2021

IBD participates in the largest international medical fair held in Düsseldorf, receiving numerous visits.

91055bdf c973 4159 b137 703dccb97666

Start of work on new headquarters

Work has started on the new headquarters of IBD Italian Biomedical Devices. The new operational headquarters will be developed on 2 floors for a total area of 1300 square meters. The structure was conceived with the aim of creating the perfect environment for the hybrid working of the future, including various areas for meetings, meetings and relaxation areas.

2021


2022

IBD flies to Dubai for Arab Health 2022

First edition of the Arab Health Exhibition for Italian Biomedical Devices complete with a visit from the Italian Ambassador to the United Arab Emirates Nicola Lener.

image009


MDR submission for new MyDial version

2023


Our Story

2014

Ghidini e Visotti

Development Activities

The MyDial technological concept has been formulated.

Foundation

In May 2014 Corrado Ghidini and Andrea Visotti founded the Start up IBD Srl and opened an R&D laboratory in Bologna (Italy).


2015

2015 Area sviluppo IBD Biomed

Development Activities

The first prototype of MyDial was developed using a PC-controlled data acquisition platform.


2016

Development Activities

The second prototype of MyDial, based on a first version of PC-independent embedded electronics, was developed and tested in the laboratory.


2017

Development Activities

IBD prototyped the Manifold, improved the ultrafiltration control and started activities to obtain the CE certification of Dial-IT

2017 Gruppo Lavoro IBD Biomed

2018

POR FESR call for innovative Startups

IBD obtained non-repayable loan of 100k€ from the Emilia-Romagna Region.

8d981281 90c3 488e 9690 d780dc8ec0d9

Third Prototype Tested and Validated

The third protype of MyDial has been tested and validated in vitro.


2019

My Dial 2019

Industrialization and Certification process

Industrialization and Certification process Industrialization of the whole MyDial system and CE certification process begins, for hospital use.

Seals of Excellence Horizon 2020

Seals of Excellence Horizon 2020 Two more seals assigned by European Commission: 867214 – 888419


2020

With the outbreak of the Covid-19 pandemic, Biorespira was born

To respond to the pandemic, engineers create the first prototype of the Biorespira lung ventilator in just 5 weeks.

Partnership with SECO Group for the industrialization of Biorespira

Partnership with SECO GROUP, a leading company in the hi-tech sector, specialized in IT miniaturization, supported by FII Tech Growth managed by the Italian Investment Fund SGR, for the industrialization of Biorespira.

Crowdfunding campaign #LETTHEMBREATHE

IBD has launched a successful crowdfunding campaign, called #LetThemBreathe, to support Biorespira’s development activities.

Development of BioRespira

During the COVID-19 pandemic, in an effort to help alleviate the emergency and shocked by the scarce presence of ventilator manufacturers in Italy, the team decided to develop a sub-intensive care ventilator with high flow and mixing of oxygen.

CE Biorespira certification

Biorespira has been tested and validated and CE certified by KIWA Cermet Italia.


2021

Biorespira patent and registration in 20 countries

Italy Ireland, Austria, Germany, Luxembourg, Poland, Slovenia, France, Spain, Cyprus, Greece, Latvia, Portugal, Belgium, Netherlands, Croatia, Lithuania, Slovakia, Haiti, Cameroon.

Biorespira records illustrious names among its sales

Among the approximately 600 devices sold there is no shortage of important hospitals such as: Osp. Maggiore (Bo), Sant’Orsola Malpighi Polyclinic (Bo), Hospital. Sant’Eugenio (Rm).

First participation in Medica 2021

IBD participates in the largest international medical fair held in Düsseldorf, receiving numerous visits.

91055bdf c973 4159 b137 703dccb97666

Start of work on new headquarters

Work has started on the new headquarters of IBD Italian Biomedical Devices. The new operational headquarters will be developed on 2 floors for a total area of 1300 square meters. The structure was conceived with the aim of creating the perfect environment for the hybrid working of the future, including various areas for meetings, meetings and relaxation areas.


2022

IBD flies to Dubai for Arab Health 2022

First edition of the Arab Health Exhibition for Italian Biomedical Devices complete with a visit from the Italian Ambassador to the United Arab Emirates Nicola Lener.

image009


2023

MDR submission for new Mydial version

Our Story

2014

Development Activities

The MyDial technological concept has been formulated.

Foundation

In May 2014 Corrado Ghidini and Andrea Visotti founded the Start up IBD Srl and opened an R&D laboratory in Bologna (Italy).


2015

Development Activities

The first prototype of MyDial was developed using a PC-controlled data acquisition platform.


2016

Development Activities

The second prototype of MyDial, based on a first version of PC-independent embedded electronics, was developed and tested in the laboratory.


2017

Development Activities

IBD prototyped the Manifold, improved the ultrafiltration control and started activities to obtain the CE certification of Dial-IT


2018

POR FESR call for innovative Startups

IBD obtained non-repayable loan of 100k€ from the Emilia-Romagna Region.

8d981281 90c3 488e 9690 d780dc8ec0d9

Third Prototype Tested and Validated

The third protype of MyDial has been tested and validated in vitro.


2019

Seals of Excellence Horizon 2020

Seals of Excellence Horizon 2020 Two more seals assigned by European Commission: 867214 – 888419


2020

With the outbreak of the Covid-19 pandemic, Biorespira was born

To respond to the pandemic, engineers create the first prototype of the Biorespira lung ventilator in just 5 weeks.

Partnership with SECO Group for the industrialization of Biorespira

Partnership with SECO GROUP, a leading company in the hi-tech sector, specialized in IT miniaturization, supported by FII Tech Growth managed by the Italian Investment Fund SGR, for the industrialization of Biorespira.

Crowdfunding campaign #LETTHEMBREATHE

IBD has launched a successful crowdfunding campaign, called #LetThemBreathe, to support Biorespira’s development activities.

Development of BioRespira

During the COVID-19 pandemic, in an effort to help alleviate the emergency and shocked by the scarce presence of ventilator manufacturers in Italy, the team decided to develop a sub-intensive care ventilator with high flow and mixing of oxygen.

CE Biorespira certification

Biorespira has been tested and validated and CE certified by KIWA Cermet Italia.


2021

Biorespira patent and registration in 20 countries

Italy Ireland, Austria, Germany, Luxembourg, Poland, Slovenia, France, Spain, Cyprus, Greece, Latvia, Portugal, Belgium, Netherlands, Croatia, Lithuania, Slovakia, Haiti, Cameroon.

Biorespira records illustrious names among its sales

Among the approximately 600 devices sold there is no shortage of important hospitals such as: Osp. Maggiore (Bo), Sant’Orsola Malpighi Polyclinic (Bo), Hospital. Sant’Eugenio (Rm).

First participation in Medica 2021

IBD participates in the largest international medical fair held in Düsseldorf, receiving numerous visits.

91055bdf c973 4159 b137 703dccb97666

Start of work on new headquarters

Work has started on the new headquarters of IBD Italian Biomedical Devices.
The new operational headquarters will be developed on 2 floors for a total area of 1300 square meters.
The structure was conceived with the aim of creating the perfect environment for the hybrid working of the future, including various areas for meetings, meetings and relaxation areas.


2022

IBD flies to Dubai for Arab Health 2022

First edition of the Arab Health Exhibition for Italian Biomedical Devices complete with a visit from the Italian Ambassador to the United Arab Emirates Nicola Lener.

image009


2023

MDR submission for new MyDial version



In compliance with the Italian Ministry of Health’s provisions regarding health advertising relating to medical devices, in vitro diagnostic medical devices and medical-surgical devices, IBD informs that the contents of this site are intended exclusively for healthcare professionals. The description of the products is for information purposes only and is not intended to promote them.

IBD ITALIAN BIOMEDICAL DEVICES SRL
Via Tasso 14 – 46043 Castiglione delle Stiviere Mantova – Italia | P.IVA 02433320203

Privacy Policy and Cookies

Follow Us

© IBD biomed All rights reserved.